News

Novo Nordisk and US biotech company team up to create obesity pills
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
CEO of Novo Nordisk, maker of Wegovy, is stepping down
Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping ...
Novo Nordisk's CEO Ousted: Deep-Value Opportunity With Sentiment Risks
Novo Nordisk A/S' CEO transition sparks governance concerns, but internal succession ensures stability. Click for my updated ...
Why Novo Nordisk Stock Just Slipped
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
Novo Nordisk should look to the US for its next CEO, analysts say
As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for ...
Novo Nordisk Woes Just Hit Denmark’s Economy. The Stock Is Rising.
That’s a bit harsh given Denmark’s strong growth compared with neighboring countries over the past few years has been largely ...
Explore more
Fierce Pharma6h
As Eli Lilly outperforms Novo in market, it also replaces its rival in annual IDEA Innovation rankings
As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index, which ...
Novo Nordisk upgraded to ’AA’ from ’AA-’ by S&P Global Ratings
Investing.com -- S&P Global Ratings has upgraded the Denmark-based pharmaceutical company Novo Nordisk (NYSE: NVO) A/S to ’AA’ from ’AA-’ due to its sustainable strong ongoing growth prospects. The ...